ACER THERAPEUTICS INC. Common Stock ($0.0001 par value per share) Sales AgreementAcer Therapeutics Inc. • November 9th, 2018 • Pharmaceutical preparations • New York
Company FiledNovember 9th, 2018 Industry JurisdictionAcer Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows: